| HLA-G |
HLA-G, HLA-6.0, HLAG: HLA class I histocompatibility antigen, alpha chain G prec |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
0.255 |
Evidence |
|
| SPTA1 |
SPTA1, SPTA: Spectrin alpha chain, erythrocyte |
UBADC1 |
UBADC1, GBDR1, KPC2: Ubiquitin-associated domain-containing protein 1 |
0.255 |
Evidence |
|
| LILRA1 |
LIR6, LILRA1: Leukocyte immunoglobulin-like receptor subfamily A member 1 precur |
CD33 |
CD33, SIGLEC3: Myeloid cell surface antigen CD33 precursor |
0.255 |
Evidence |
|
| REG1B |
REG1B, REGL: Lithostathine 1 beta precursor |
PRSS2 |
PRSS2, TRY2, TRYP2: Trypsin-2 precursor |
0.255 |
Evidence |
|
| FGL2 |
FGL2: Fibroleukin precursor |
LOC645419 |
MEGF9, EGFL5, UNQ671/PRO1305, KIAA0818: Multiple epidermal growth factor-like do |
0.255 |
Evidence |
|
| MYO1F |
MYO1F: Myosin-If |
VASP |
VASP: Vasodilator-stimulated phosphoprotein |
0.255 |
Evidence |
|
| ITGAL |
ITGAL, CD11A: Integrin alpha-L precursor |
HLA-F |
HLA-F, HLA-5.4, HLAF: HLA class I histocompatibility antigen, alpha chain F prec |
0.255 |
Evidence |
|
| IL18RAP |
IL18RAP: Interleukin-18 receptor accessory protein precursor |
CLEC2B |
CLEC2B, AICL, CLECSF2, IFNRG1: C-type lectin domain family 2 member B |
0.255 |
Evidence |
|
| ACTG1 |
ACTR2, ARP2: Actin-related protein 2 |
TMSB4X |
TMSB4X, TB4X, THYB4, TMSB4: Thymosin beta-4 |
0.255 |
Evidence |
|
| ACR |
ACR, ACRS: Acrosin precursor |
CCIN |
CCIN: Calicin |
0.255 |
Evidence |
|
| SNCB |
SNCB: Beta-synuclein |
CAMK2A |
CAMK2A, CAMKA, KIAA0968: Calcium/calmodulin-dependent protein kinase type II alp |
0.255 |
Evidence |
|
| CYR61 |
CYR61, CCN1, GIG1, IGFBP10: Protein CYR61 precursor |
COL1A2 |
IPI00164755 |
0.255 |
Evidence |
|
| KLRC2 |
KLRC2, NKG2C: NKG2-C type II integral membrane protein |
KLRK1 |
KLRK1, D12S2489E, NKG2D: NKG2-D type II integral membrane protein |
0.255 |
Evidence |
|
| KRAS |
IPI00423570 |
RALBP1 |
RALBP1, RLIP1, RLIP76: RalA-binding protein 1 |
0.255 |
Evidence |
|
| RNF4 |
RNF4, RES4-26: RING finger protein 4 |
TRIM14 |
TRIM14, KIAA0129: Tripartite motif-containing protein 14 |
0.255 |
Evidence |
|
| CCL2 |
CCL2, MCP1, SCYA2: Small-inducible cytokine A2 precursor |
TNFAIP6 |
TNFAIP6, TSG6: Tumor necrosis factor-inducible protein TSG-6 precursor |
0.255 |
Evidence |
|
| PRKD2 |
PRKD2, PKD2, HSPC187: Serine/threonine-protein kinase D2 |
ARHGEF18 |
ARHGEF18: ARHGEF18 protein |
0.255 |
Evidence |
|
| DHX15 |
DHX15, DBP1, DDX15: Putative pre-mRNA-splicing factor ATP-dependent RNA helicase |
SMARCA5 |
SMARCA5, SNF2H, WCRF135: SWI/SNF-related matrix-associated actin-dependent regul |
0.255 |
Evidence |
|
| TIMP3 |
TIMP3: Metalloproteinase inhibitor 3 precursor |
PSG3 |
PSG3: Pregnancy-specific beta-1-glycoprotein 3 precursor |
0.255 |
Evidence |
|
| C4BPA |
C4BPA, C4BP: C4b-binding protein alpha chain precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
| HGFAC |
HGFAC: Hepatocyte growth factor activator precursor |
HABP2 |
HABP2, HGFAL, PHBP: Hyaluronan-binding protein 2 precursor |
0.255 |
Evidence |
|
| CD1D |
CD1D: T-cell surface glycoprotein CD1d precursor |
IGSF6 |
IGSF6, DORA: Immunoglobulin superfamily member 6 precursor. |
0.255 |
Evidence |
|
| HLA-E |
HLA-E, XXbac-BPG34K20.2-001: MHC class Ib antigen |
ADAM8 |
ADAM8, MS2: ADAM 8 precursor |
0.255 |
Evidence |
|
| TLR2 |
TLR2, TIL4: Toll-like receptor 2 precursor |
TREM1 |
TREM1: Triggering receptor expressed on myeloid cells 1 precursor |
0.255 |
Evidence |
|
| MATR3 |
MATR3, KIAA0723: Matrin-3 |
UPF2 |
UPF2, KIAA1408, RENT2: Regulator of nonsense transcripts 2 |
0.255 |
Evidence |
|